Daidzein and genistein are converted to equol and 5-hydroxy-equol by human intestinal slackia isoflavoniconvertens in gnotobiotic rats

Journal of Nutrition

Volumn 142, Issue 1, 2012, Pages 40-46

  Matthies, Anastasia ^a   Loh, Gunnar ^a   Blaut, Michael ^a   Braune, Annett ^a  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXY EQUOL; CHROMAN DERIVATIVE; CHROMONE DERIVATIVE; DAIDZEIN; DIHYDRODAIDZEIN; DIHYDROGENISTEIN; DRUG METABOLITE; EQUOL; GENISTEIN; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG METABOLISM; FECES ANALYSIS; FEMALE; GNOTOBIOTICS; IN VIVO STUDY; INTESTINE FLORA; MALE; MICROFLORA; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; SEX DIFFERENCE; SLACKIA ISOFLAVONICONVERTENS; STOMACH JUICE; URINALYSIS;

ACTINOBACTERIA; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLONY COUNT, MICROBIAL; EQUOL; FEMALE; GENISTEIN; GERM-FREE LIFE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTESTINES; ISOFLAVONES; MALE; RATS; REAL-TIME POLYMERASE CHAIN REACTION;

RATTUS; SLACKIA;

EID: 84855565780     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.111.148247     Document Type: Article

References (44)

1. Setchell KD, Cassidy A. Dietary isoflavones: biological effects and relevance to human health. J Nutr. 1999;129:S758-67.
2. Steiner C, Arnould S, Scalbert A, Manach C. Isoflavones and the prevention of breast and prostate cancer: new perspectives opened by nutrigenomics. Br J Nutr. 2008;99 E Suppl 1:ES78-108.
3. Rimbach G, Boesch-Saadatmandi C, Frank J, Fuchs D, Wenzel U, Daniel H, Hall WL, Weinberg PD. Dietary isoflavones in the prevention of cardiovascular disease: a molecular perspective. Food Chem Toxicol. 2008;46:1308-19.
4. Ørgaard A, Jensen L. The effects of soy isoflavones on obesity. Exp Biol Med (Maywood). 2008;233:1066-80.
5. Ariazi EA, Jordan VC. Estrogen-related receptors as emerging targets in cancer and metabolic disorders. Curr Top Med Chem. 2006;6:203-15.
6. Hwang CS, Kwak HS, Lim HJ, Lee SH, Kang YS, Choe TB, Hur HG, Han KO. Isoflavone metabolites and their in vitro dual functions: they can act as an estrogenic agonist or antagonist depending on the estrogen concentration. J Steroid Biochem Mol Biol. 2006;101:246-53.
7. Zhou JR, Li L, Pan W. Dietary soy and tea combinations for prevention of breast and prostate cancers by targeting metabolic syndrome elements in mice. Am J Clin Nutr. 2007;86:s882-8.
8. Barnes S. The biochemistry, chemistry and physiology of the isoflavones in soybeans and their food products. Lymphat Res Biol. 2010;8:89-98.
9. Setchell KD, Clerici C. Equol: pharmacokinetics and biological actions. J Nutr. 2010;140:S1363-8.
10. Setchell KD, Clerici C. Equol: history, chemistry, and formation. J Nutr. 2010;140:S1355-62.
11. Jin JS, Kitahara M, Sakamoto M, Hattori M, Benno Y. Slackia equolifaciens sp. nov., a human intestinal bacterium capable of producing equol. Int J Syst Evol Microbiol. 2010;60:1721-4.
12. Maruo T, Sakamoto M, Ito C, Toda T, Benno Y. Adlercreutzia equolifaciens gen. nov., sp. nov., an equol-producing bacterium isolated from human faeces, and emended description of the genus Eggerthella. Int J Syst Evol Microbiol. 2008;58:1221-7.
13. Matthies A, Blaut M, Braune A. Isolation of a human intestinal bacterium capable of daidzein and genistein conversion. Appl Environ Microbiol. 2009;75:1740-4.
14. Uchiyama S, Ueno T, Suzuki T. Identification of a newly isolated equolproducing lactic acid bacterium from the human feces. J Intest Microbiol. 2007;21:217-20.
15. Bowey E, Adlercreutz H, Rowland I. Metabolism of isoflavones and lignans by the gut microflora: a study in germ-free and human flora associated rats. Food Chem Toxicol. 2003;41:631-6.
16. Matthies A, Clavel T, Gütschow M, EngstW, Haller D, BlautM, Braune A. Conversion of daidzein and genistein by an anaerobic bacterium newly isolated from the mouse intestine. Appl Environ Microbiol. 2008;74:4847-52.
17. Clavel T, Charrier C, Braune A, Wenning M, Blaut M, Haller D. Isolation of bacteria from the ileal mucosa of TNFDARE mice and description of Enterorhabdus mucosicola gen. nov., sp. nov. Int J Syst Evol Microbiol. 2009;59:1805-12.
18. Becker N, Kunath J, Loh G, Blaut M. Human intestinal microbiota: characterization of a simplified and stable gnotobiotic rat model. Gut Microbes. 2011;2:25-33.
19. Degen GH, Janning P, Diel P, Bolt HM. Estrogenic isoflavones in rodent diets. Toxicol Lett. 2002;128:145-57.
20. Thiel R, Blaut M. An improved method for the automated enumeration of fluorescently labelled bacteria in human faeces. JMicrobiol Methods. 2005;61:369-79.
21. Tsuji H, Moriyama K, Nomoto K,Miyanaga N, Akaza H. Isolation and characterization of the equol-producing bacterium Slackia sp. strain NATTS. Arch Microbiol. 2010;192:279-87.
22. Hanske L, Loh G, Sczesny S, Blaut M, Braune A. The bioavailability of apigenin-7-glucoside is influenced by human intestinal microbiota in rats. J Nutr. 2009;139:1095-102.
23. Morton MS, Arisaka O, Miyake N, Morgan LD, Evans BA. Phytoestrogen concentrations in serum from Japanese men and women over forty years of age. J Nutr. 2002;132:3168-71.
24. Gu L, House SE, Prior RL, Fang N, Ronis MJ, Clarkson TB, Wilson ME, Badger TM. Metabolic phenotype of isoflavones differ among female rats, pigs, monkeys, and women. J Nutr. 2006;136:1215-21.
25. Setchell KD, Cole SJ. Method of defining equol-producer status and its frequency among vegetarians. J Nutr. 2006;136:2188-93.
26. Faughnan MS, Hawdon A, Ah-Singh E, Brown J, Millward DJ, Cassidy A. Urinary isoflavone kinetics: the effect of age, gender, food matrix and chemical composition. Br J Nutr. 2004;91:567-74.
27. King RA, Bursill DB. Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans. Am J Clin Nutr. 1998;67:867-72.
28. Setchell KD, Brown NM, Desai PB, Zimmer-Nechimias L, Wolfe B, Jakate AS, Creutzinger V, Heubi JE. Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes. J Nutr. 2003;133:1027-35.
29. Watanabe S, Yamaguchi M, Sobue T, Takahashi T, Miura T, Arai Y, Mazur W, Wähälä K, Adlercreutz H. Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako). J Nutr. 1998;128:1710-5.
30. Appelt LC, Reicks MM. Soy induces phase II enzymes but does not inhibit dimethylbenz[a]anthracene-induced carcinogenesis in female rats. J Nutr. 1999;129:1820-6.
31. Froyen EB, Reeves JL, Mitchell AE, Steinberg FM. Regulation of phase II enzymes by genistein and daidzein in male and female Swiss Webster mice. J Med Food. 2009;12:1227-37.
32. Sfakianos J, Coward L, Kirk M, Barnes S. Intestinal uptake and biliary excretion of the isoflavone genistein in rats. J Nutr. 1997;127:1260-8.
33. Ronis MJ, Little JM, Barone GW, Chen G, Radominska-Pandya A, Badger TM. Sulfation of the isoflavones genistein and daidzein in human and rat liver and gastrointestinal tract. J Med Food. 2006;9:348-55.
34. Zhang Y, Song TT, Cunnick JE, Murphy PA, Hendrich S. Daidzein and genistein glucuronides in vitro are weakly estrogenic and activate human natural killer cells at nutritionally relevant concentrations. J Nutr. 1999;129:399-405.
35. Chen J, Wang S, Jia X, Bajimaya S, Lin H, Tam VH, Hu M. Disposition of flavonoids via recycling: comparison of intestinal versus hepatic disposition. Drug Metab Dispos. 2005;33:1777-84.
36. Wang SW, Chen J, Jia X, Tam VH, Hu M. Disposition of flavonoids via enteric recycling: structural effects and lack of correlations between in vitro and in situ metabolic properties. Drug Metab Dispos. 2006; 34:1837-48.
37. McBain AJ, Macfarlane GT. Ecological and physiological studies on large intestinal bacteria in relation to production of hydrolytic and reductive enzymes involved in formation of genotoxic metabolites. J Med Microbiol. 1998;47:407-16.
38. Zhang L, Zuo Z, Lin G. Intestinal and hepatic glucuronidation of flavonoids. Mol Pharm. 2007;4:833-45.
39. Shelby MK, Cherrington NJ, Vansell NR, Klaassen CD. Tissue mRNA expression of the rat UDP-glucuronosyltransferase gene family. Drug Metab Dispos. 2003;31:326-33.
40. Takeuchi T, Tsutsumi O, Nakamura N, Ikezuki Y, Takai Y, Yano T, Taketani Y. Gender difference in serum bisphenol A levels may be caused by liver UDP-glucuronosyltransferase activity in rats. Biochem Biophys Res Commun. 2004;325:549-54.
41. Vrieling A, Rookus MA, Kampman E, Bonfrer JM, Korse CM, van Doorn J, Lampe JW, Cats A, Witteman BJ, van Leeuwen FE, et al. Isolated isoflavones do not affect the circulating insulin-like growth factor system in men at increased colorectal cancer risk. J Nutr. 2007;137:379-83.
42. Frystyk J, Gronbaek H, Skjaerbaek C, Flyvbjerg A, Orskov H, Baxter RC. Developmental changes in serum levels of free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acidlabile subunit in rats. Endocrinology. 1998;139:4286-92.
43. Fukuda R, Usuki S, Mukai N, Amagai H, Hayashi K, Takamatsu K. Serum insulin-like growth factor-I, insulin-like growth factor binding protein-3, sex steroids, osteocalcin and bone mineral density in male and female rats. Gynecol Endocrinol. 1998;12:297-305.
44. Landin-Wilhelmsen K, Lundberg PA, Lappas G, Wilhelmsen L. Insulinlike growth factor I levels in healthy adults. Horm Res. 2004;62:8-16.